
Clene Inc. — Investor Relations & Filings
Clene Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing nanotherapeutics to treat neurodegenerative diseases. The company's approach centers on its proprietary technology platform, which creates clean-surfaced, catalytically-active nanocrystals. These nanotherapeutics are designed to address cellular energy impairments, a key factor in the progression of many neurological conditions. By targeting these bioenergetic deficits, Clene aims to restore and protect neuronal health and function. The company is advancing a pipeline of drug candidates to address high unmet medical needs in diseases such as amyotrophic lateral sclerosis (ALS) and multiple sclerosis.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM SD | 2026-05-22 | English | |
| FORM 8-K | 2026-05-22 | English | |
| FORM 8-K | 2026-05-14 | English | |
| FORM 10-Q | 2026-05-14 | English | |
| 424B5 - Clene Inc. (0001822791) (Filer) | 2026-05-05 | English | |
| 424B5 - Clene Inc. (0001822791) (Filer) | 2026-05-05 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46860589 | FORM SD | 2026-05-22 | English | ||
| 46860002 | FORM 8-K | 2026-05-22 | English | ||
| 45994087 | FORM 8-K | 2026-05-14 | English | ||
| 45988453 | FORM 10-Q | 2026-05-14 | English | ||
| 41552311 | 424B5 - Clene Inc. (0001822791) (Filer) | 2026-05-05 | English | ||
| 41541458 | 424B5 - Clene Inc. (0001822791) (Filer) | 2026-05-05 | English | ||
| 40890003 | 8-K - Clene Inc. (0001822791) (Filer) | 2026-05-04 | English | ||
| 32963513 | 10-K - Clene Inc. (0001822791) (Filer) | 2026-03-17 | English | ||
| 32899074 | 8-K - CLENE INC. (0001822791) (Filer) | 2026-02-24 | English | ||
| 32899066 | 4 - CLENE INC. (0001822791) (Filer) | 2026-02-20 | English | ||
| 32899067 | 4 - CLENE INC. (0001822791) (Filer) | 2026-02-20 | English | ||
| 32899068 | 4 - CLENE INC. (0001822791) (Filer) | 2026-02-20 | English | ||
| 32899069 | 4 - CLENE INC. (0001822791) (Filer) | 2026-02-20 | English | ||
| 32899072 | 4 - CLENE INC. (0001822791) (Filer) | 2026-02-20 | English | ||
| 32899070 | 4 - CLENE INC. (0001822791) (Filer) | 2026-02-20 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ARGENT BIOPHARMA LIMITED
Develops plant-inspired and synthetic medicines for neurolo…
|
RGT | AU | Manufacturing |
|
argenx SE
Develops and commercializes antibody-based therapies for se…
|
1AE | NL | Manufacturing |
|
Armata Pharmaceuticals, Inc.
Develops bacteriophage therapeutics for antibiotic-resistan…
|
ARMP | US | Manufacturing |
|
AroCell AB
Develops and markets in vitro diagnostic (IVD) tests for on…
|
AROC | SE | Manufacturing |
|
ArriVent BioPharma, Inc.
Clinical-stage biopharma developing oncology drugs for diff…
|
AVBP | US | Manufacturing |
|
ARROWHEAD PHARMACEUTICALS, INC.
Biotechnology company developing RNAi therapies to treat in…
|
ARWR | US | Manufacturing |
|
ARS Pharmaceuticals, Inc.
Develops and commercializes needle-free products for admini…
|
SPRY | US | Manufacturing |
|
ARTELO BIOSCIENCES, INC.
Clinical-stage biopharma developing therapeutics by modulat…
|
ARTL | US | Manufacturing |
|
Arura Pharma Inc
Diversified manufacturer and distributor in consumer goods …
|
— | CA | Manufacturing |
|
Ascelia Pharma
Biotechnology company developing and commercializing novel …
|
ACE | SE | Manufacturing |
Clene Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34487/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34487 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34487 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34487 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34487}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Clene Inc. (id: 34487)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.